Fri, Sep 29, 2023
Healthcare Sector M&A Industry Insights – Fall 2023
In this edition of the Healthcare Report we identify trends and provide insights across the sector, focusing on key themes, issues and opportunities.
Highlights:
- For the year to date (YTD) ended 8/22/2023, the S&P Healthcare (Sector) Index decreased 2.1%, compared to an increase of 14.6% for the S&P 500 Index
- The sectors that experienced the largest increase were consumer-directed health and wellness (up 16.4%), assisted/independent Living (up 14.6%), and specialty managed care (up 8.0%)
- The sectors that experienced the largest decrease were care platforms (facility-based) (down 43.8%), care platforms (affiliate-based) (down 10.4%), and med-tech and devices (down 8.5%)
- The current average last 12 months (LTM) revenue and LTM EBITDA multiples for the Healthcare industry overall are 1.8x and 11.5x, respectively
- While Healthcare EBITDA multiples decreased modestly in the seven months ended July 31, 2023 compared to full year 2022, they remained relatively strong on a historical basis
Healthcare Sector M&A Industry Insights Valuation Data
Our Healthcare report aims to identify trends and provide insights across the sector, focusing on key themes, issues and opportunities. To view additional valuation data and public company trading statistics, download our M&A Valuation Data.
Healthcare Investment Banking
Healthcare expertise for middle-market M&A transactions.
Corporate Finance and Restructuring
M&A advisory, restructuring and insolvency, debt advisory, strategic alternatives, transaction diligence and independent financial opinions.
Mergers and Acquisitions (M&A) Advisory
Kroll’s investment banking practice has extensive experience in M&A deal strategy and structuring, capital raising, transaction advisory services and financial sponsor coverage.